| Literature DB >> 18342381 |
R E Drzymala1, T H Wasserman, M Won, E Shaw, A J Cmelak, J Loeffler, L Souhami.
Abstract
RTOG 95-02 assessed patient tolerance to hypoxic cell radiosensitizer, etanidazole (SR-2508), combined with radiosurgery. Patients had primary or metastatic brain tumors and previously localized or whole brain irradiation. The toxicity is reported in three groups of patients according to the tumor size. Etanidazole doses of 12g/m2 combined with radiosurgery were well tolerated.Entities:
Mesh：
Substances：
Year: 2008 PMID： 18342381 DOI： 10.1016/j.radonc.2008.02.006
Source DB: PubMed Journal: Radiother Oncol ISSN： 0167-8140 Impact factor: 6.280